Sio Capital Management as of June 30, 2021
Portfolio Holdings for Sio Capital Management
Sio Capital Management holds 73 positions in its portfolio as reported in the June 2021 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Ascendis Pharma A/s Spons Adr Put Option (ASND) | 8.2 | $33M | 252k | 131.55 | |
Curis Com New | 6.7 | $27M | 3.4M | 8.07 | |
Cigna Corp (CI) | 5.1 | $21M | 87k | 237.07 | |
Soliton | 4.6 | $19M | 825k | 22.49 | |
Spdr Gold Shares Gold Shs (GLD) | 3.9 | $16M | 95k | 165.63 | |
Aveanna Healthcare Hldgs (AVAH) | 3.7 | $15M | 1.2M | 12.37 | |
Hca Holdings (HCA) | 3.4 | $14M | 66k | 206.75 | |
Centene Corporation (CNC) | 2.8 | $11M | 156k | 72.93 | |
Universal Health Services CL B (UHS) | 2.7 | $11M | 73k | 146.43 | |
McKesson Corporation (MCK) | 2.4 | $9.5M | 50k | 191.24 | |
Albireo Pharma | 2.3 | $9.3M | 266k | 35.18 | |
Hill-Rom Holdings | 2.2 | $8.7M | 77k | 113.59 | |
Amgen (AMGN) | 2.1 | $8.5M | 35k | 243.74 | |
United Therapeutics Corporation (UTHR) | 2.1 | $8.4M | 47k | 179.42 | |
Herbalife Nutrition Com Shs (HLF) | 2.0 | $8.2M | 155k | 52.73 | |
Mirum Pharmaceuticals (MIRM) | 2.0 | $7.9M | 455k | 17.29 | |
Spruce Biosciences (SPRB) | 1.8 | $7.3M | 647k | 11.21 | |
Horizon Therapeutics SHS | 1.6 | $6.3M | 68k | 93.64 | |
Integer Hldgs (ITGR) | 1.6 | $6.3M | 67k | 94.20 | |
Affimed Therapeutics B V | 1.5 | $6.1M | 715k | 8.50 | |
Coherus Biosciences (CHRS) | 1.4 | $5.7M | 414k | 13.83 | |
Syneos Health Cl A | 1.4 | $5.6M | 63k | 89.49 | |
Ayala Pharmaceuticals Incorporated | 1.4 | $5.5M | 543k | 10.19 | |
X4 Pharmaceuticals (XFOR) | 1.3 | $5.2M | 805k | 6.50 | |
Healthequity (HQY) | 1.3 | $5.2M | 65k | 80.48 | |
Aslan Pharmaceuticals Ads | 1.2 | $4.9M | 1.5M | 3.30 | |
Vertex Pharmaceuticals Incorporated (VRTX) | 1.2 | $4.8M | 24k | 201.63 | |
Kura Oncology (KURA) | 1.2 | $4.6M | 222k | 20.85 | |
Cross Country Healthcare (CCRN) | 1.1 | $4.6M | 280k | 16.51 | |
Radius Health Com New | 1.1 | $4.4M | 241k | 18.24 | |
Chardan Healthcare Acquisition 2 Corp Unit | 1.1 | $4.4M | 400k | 10.92 | |
Syros Pharmaceuticals | 1.1 | $4.4M | 800k | 5.45 | |
Inari Medical Ord (NARI) | 1.1 | $4.3M | 46k | 93.28 | |
Essa Pharma Com New (EPIX) | 1.1 | $4.2M | 148k | 28.57 | |
Neubase Therapeutics Ord | 1.0 | $4.2M | 869k | 4.79 | |
Ardelyx (ARDX) | 1.0 | $4.0M | 526k | 7.58 | |
Autolus Therapeutics Spon Ads (AUTL) | 1.0 | $3.9M | 592k | 6.64 | |
Viking Therapeutics (VKTX) | 0.9 | $3.7M | 620k | 5.99 | |
Moleculin Biotech | 0.9 | $3.7M | 1.0M | 3.67 | |
Precision Biosciences Ord | 0.9 | $3.7M | 293k | 12.52 | |
Rigel Pharmaceuticals Com New | 0.9 | $3.6M | 830k | 4.34 | |
On Assignment (ASGN) | 0.9 | $3.6M | 37k | 96.94 | |
Eucrates Biomedical Acquisition Corp. Unit 10/23/2027 | 0.8 | $3.1M | 300k | 10.20 | |
Macrogenics (MGNX) | 0.8 | $3.0M | 113k | 26.86 | |
Aeglea Biotherapeutics | 0.7 | $2.8M | 403k | 6.96 | |
Catalyst Biosciences Com New | 0.7 | $2.7M | 624k | 4.33 | |
Proqr Therapeutics Nv Shs Euro (PRQR) | 0.6 | $2.6M | 380k | 6.74 | |
Health Sciences Acquisitions Corp 2 Ord Shs | 0.6 | $2.6M | 250k | 10.20 | |
AMN Healthcare Services (AMN) | 0.6 | $2.5M | 26k | 97.00 | |
Cyclacel Pharmaceuticals | 0.6 | $2.5M | 417k | 5.92 | |
Cymabay Therapeutics | 0.6 | $2.5M | 562k | 4.36 | |
Travere Therapeutics (TVTX) | 0.5 | $2.2M | 150k | 14.59 | |
Fusion Pharmaceuticals | 0.5 | $2.2M | 266k | 8.08 | |
Mersana Therapeutics (MRSN) | 0.5 | $2.1M | 157k | 13.58 | |
Gossamer Bio (GOSS) | 0.5 | $2.1M | 261k | 8.12 | |
Chardan Healthcr Acqstn 2 | 0.5 | $2.0M | 200k | 9.96 | |
Cardinal Health (CAH) | 0.5 | $1.9M | 34k | 57.10 | |
Vincerx Pharma Com New (VINC) | 0.5 | $1.8M | 141k | 12.99 | |
Sierra Oncology Com New | 0.5 | $1.8M | 93k | 19.47 | |
Arena Pharmaceuticals Com New | 0.4 | $1.5M | 22k | 68.22 | |
Salarius Pharmaceuticals Com New | 0.4 | $1.4M | 1.4M | 1.06 | |
Mei Pharma Com New | 0.3 | $1.2M | 426k | 2.85 | |
Alpha Healthcare Acquisition Corp Unit 10/01/2023 | 0.3 | $1.1M | 100k | 11.41 | |
Ideaya Biosciences (IDYA) | 0.3 | $1.0M | 48k | 20.99 | |
Atreca Cl A Com (BCEL) | 0.2 | $967k | 114k | 8.52 | |
Fulcrum Therapeutics (FULC) | 0.2 | $812k | 78k | 10.48 | |
Logicbio Therapeutics | 0.2 | $811k | 183k | 4.44 | |
Seer Com Cl A (SEER) | 0.2 | $779k | 24k | 32.77 | |
Caremax Com Cl A | 0.1 | $562k | 44k | 12.91 | |
CVRX (CVRX) | 0.1 | $420k | 15k | 28.00 | |
Mesoblast Spons Adr Put Option | 0.1 | $410k | 55k | 7.48 | |
Neoleukin Therapeutics | 0.1 | $354k | 38k | 9.24 | |
Rubius Therapeutics | 0.0 | $151k | 6.2k | 24.35 |